"Two things that are top priorities in the pharmaceutical industry at the global level are these: One, setting the 'gold' standard, meaning that the drug product is viewed as valuable as gold; and two, quality by design, that is, build in quality rather than try to achieve it as an end-result."
Bindhumadhavan Gururajan, Senior Scientist (Product Development) at AstraZeneca Pharmaceutical and Analytical R&D, Loughborough, UK
January 10, over lunch
Book Peek - March 14, 2013- Preeti, Amish Special - Preview - Book Peek - March 14, 2013- Preeti, Amish Special - Preview by D. Murali
4 years ago